vs

Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $186.7M, roughly 1.6× NEOGENOMICS INC). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs -57.9%, a 70.8% gap on every dollar of revenue. Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 0.6%).

Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

HTH vs NEO — Head-to-Head

Bigger by revenue
HTH
HTH
1.6× larger
HTH
$300.5M
$186.7M
NEO
Higher net margin
HTH
HTH
70.8% more per $
HTH
13.0%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
0.6%
HTH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
HTH
HTH
NEO
NEO
Revenue
$300.5M
$186.7M
Net Profit
$39.0M
$-108.0M
Gross Margin
43.3%
Operating Margin
46.9%
Net Margin
13.0%
-57.9%
Revenue YoY
11.1%
Net Profit YoY
-12.4%
42.0%
EPS (diluted)
$0.64
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTH
HTH
NEO
NEO
Q1 26
$300.5M
$186.7M
Q4 25
$329.9M
$190.2M
Q3 25
$330.2M
$187.8M
Q2 25
$303.3M
$181.3M
Q1 25
$318.5M
$168.0M
Q4 24
$301.1M
$172.0M
Q3 24
$305.5M
$167.8M
Q2 24
$297.0M
$164.5M
Net Profit
HTH
HTH
NEO
NEO
Q1 26
$39.0M
$-108.0M
Q4 25
$41.6M
Q3 25
$45.8M
$-27.1M
Q2 25
$36.1M
$-45.1M
Q1 25
$42.1M
$-25.9M
Q4 24
$35.5M
Q3 24
$29.7M
$-17.7M
Q2 24
$20.3M
$-18.6M
Gross Margin
HTH
HTH
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
HTH
HTH
NEO
NEO
Q1 26
46.9%
Q4 25
16.1%
-7.1%
Q3 25
18.4%
-14.4%
Q2 25
16.3%
-26.3%
Q1 25
18.1%
-16.6%
Q4 24
14.7%
-10.7%
Q3 24
13.9%
-12.6%
Q2 24
10.0%
-13.3%
Net Margin
HTH
HTH
NEO
NEO
Q1 26
13.0%
-57.9%
Q4 25
12.6%
Q3 25
13.9%
-14.4%
Q2 25
11.9%
-24.9%
Q1 25
13.2%
-15.4%
Q4 24
11.8%
Q3 24
9.7%
-10.5%
Q2 24
6.8%
-11.3%
EPS (diluted)
HTH
HTH
NEO
NEO
Q1 26
$0.64
$-0.13
Q4 25
$0.68
Q3 25
$0.74
Q2 25
$0.57
Q1 25
$0.65
Q4 24
$0.55
Q3 24
$0.46
Q2 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTH
HTH
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$146.1M
Total DebtLower is stronger
$990.8M
Stockholders' EquityBook value
$2.2B
$828.8M
Total Assets
$15.7B
$1.3B
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTH
HTH
NEO
NEO
Q1 26
$146.1M
Q4 25
$159.6M
Q3 25
$164.1M
Q2 25
$154.7M
Q1 25
$346.2M
Q4 24
$367.0M
Q3 24
$362.0M
Q2 24
$355.1M
Total Debt
HTH
HTH
NEO
NEO
Q1 26
$990.8M
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
HTH
HTH
NEO
NEO
Q1 26
$2.2B
$828.8M
Q4 25
$2.2B
$836.6M
Q3 25
$2.2B
$838.3M
Q2 25
$2.2B
$854.0M
Q1 25
$2.2B
$888.3M
Q4 24
$2.2B
$902.3M
Q3 24
$2.2B
$908.2M
Q2 24
$2.1B
$915.9M
Total Assets
HTH
HTH
NEO
NEO
Q1 26
$15.7B
$1.3B
Q4 25
$15.8B
$1.4B
Q3 25
$15.6B
$1.4B
Q2 25
$15.4B
$1.4B
Q1 25
$15.8B
$1.6B
Q4 24
$16.3B
$1.6B
Q3 24
$15.9B
$1.6B
Q2 24
$15.6B
$1.6B
Debt / Equity
HTH
HTH
NEO
NEO
Q1 26
0.46×
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTH
HTH
NEO
NEO
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTH
HTH
NEO
NEO
Q1 26
$-8.1M
Q4 25
$-38.7M
$1.3M
Q3 25
$273.0M
$8.9M
Q2 25
$-234.6M
$20.3M
Q1 25
$5.8M
$-25.3M
Q4 24
$273.9M
$9.8M
Q3 24
$515.6M
$9.2M
Q2 24
$-435.3M
$13.9M
Free Cash Flow
HTH
HTH
NEO
NEO
Q1 26
Q4 25
$-55.5M
$-6.5M
Q3 25
$271.0M
$570.0K
Q2 25
$-234.6M
$14.0M
Q1 25
$5.0M
$-29.8M
Q4 24
$266.8M
$-1.8M
Q3 24
$513.8M
$-1.6M
Q2 24
$-437.3M
$814.0K
FCF Margin
HTH
HTH
NEO
NEO
Q1 26
Q4 25
-16.8%
-3.4%
Q3 25
82.1%
0.3%
Q2 25
-77.4%
7.7%
Q1 25
1.6%
-17.8%
Q4 24
88.6%
-1.0%
Q3 24
168.2%
-0.9%
Q2 24
-147.2%
0.5%
Capex Intensity
HTH
HTH
NEO
NEO
Q1 26
Q4 25
5.1%
4.1%
Q3 25
0.6%
4.4%
Q2 25
0.0%
3.5%
Q1 25
0.3%
2.7%
Q4 24
2.4%
6.7%
Q3 24
0.6%
6.4%
Q2 24
0.7%
8.0%
Cash Conversion
HTH
HTH
NEO
NEO
Q1 26
Q4 25
-0.93×
Q3 25
5.96×
Q2 25
-6.50×
Q1 25
0.14×
Q4 24
7.71×
Q3 24
17.36×
Q2 24
-21.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTH
HTH

Noninterest Income$188.4M63%
Net Interest Income$112.1M37%

NEO
NEO

Segment breakdown not available.

Related Comparisons